HIKAL
Back to Income Statement
|
HIKAL Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹267 Cr | ₹257 Cr | ₹341 Cr | ₹323 Cr | ₹273 Cr |
What is the latest Operating Profit of HIKAL ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹267 Cr |
| Mar2024 | ₹257 Cr |
| Mar2023 | ₹341 Cr |
| Mar2022 | ₹323 Cr |
| Mar2021 | ₹273 Cr |
How is Operating Profit of HIKAL Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹267 Cr | 3.86 | |
| Mar2024 | ₹257 Cr | -24.51 | |
| Mar2023 | ₹341 Cr | 5.47 | |
| Mar2022 | ₹323 Cr | 18.20 | |
| Mar2021 | ₹273 Cr | - | |
Compare Operating Profit of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,516.6 Cr | -3.9% | -5.8% | -19.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -3.9% |
-5.8% |
-19.6% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses